(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky? - 2Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
- 3Lebanon says Israeli strike killed 13 people near Palestinian refugee camp
- 4Vote in favor of Your #1 Home Exercise Gear: Execution and Comfort Matter
- 5Syria rejects forced deportations from Germany amid migration debate
- Nations for Youngsters to Visit
- NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- A somber Thor is returning for 'Avengers: Doomsday': Watch the dread-filled teaser
- This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- Struggling to keep your New Year's resolutions? Here's how to keep yourself on track
- The Most Compelling Books of the 10 years
- 23 Most Amusing Messages At any point Sent Among Kids and Their Folks
- Fundamental Venture The board Apparatuses for Remote Groups
- Figure out How to Recognize Early Indications of Depressions
